BeOne Medicines (ONC) Change in Cash (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Change in Cash data on file, last reported at $243.8 million in Q1 2026.

• On a quarterly basis, Change in Cash rose 325.39% year-over-year to $243.8 million in Q1 2026; TTM through Mar 2026 was $2.3 billion, a 939.04% increase from a year earlier, with the FY2025 full-year figure at $2.0 billion, up 460.15% from the prior year.
• Change in Cash for Q1 2026 stood at $243.8 million, down from $499.1 million in the prior quarter.
• Over the last five years, Change in Cash for ONC reached as high as $1.3 billion in Q3 2025 and fell as low as -$378.5 million in Q1 2024.
• Historically, Change in Cash has averaged $27.7 million across 5 years, with a median of -$74.7 million in 2024.
• Across the five-year window, Change in Cash sank 1064.93% in 2023 and jumped 1286.91% in 2025, its largest moves.
• Year by year, Change in Cash stood at -$325.5 million in 2022, then soared by 132.29% to $105.1 million in 2023, then sank by 171.06% to -$74.7 million in 2024, then surged by 768.32% to $499.1 million in 2025, then plunged by 51.16% to $243.8 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $243.8 million in Q1 2026, $499.1 million in Q4 2025, and $1.3 billion in Q3 2025.